ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) CEO Adam S. Grossman sold 100,000 shares of the firm’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $10.72, for a total value of $1,072,000.00. Following the sale, the chief executive officer now owns 2,081,475 shares of the […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 8,720,000 shares, a growth of 7.5% from the April 15th total of 8,110,000 shares. Based on an average daily volume of 2,540,000 shares, the days-to-cover ratio […]
ADMA Biologics (NASDAQ:ADMA) Shares Gap Up Following Strong Earnings themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) shares reached a new 52-week high on Friday . The company traded as high as $6.80 and last traded at $6.70, with a volume of 708040 shares. The stock had previously closed at $6.74. Analyst Ratings Changes A number of equities research analysts recently weighed in on […]